Melissa Bailey
AMS-Associate Administrator (Departed Administration)
Estimated Net Worth
  • estimated net worth
    $258 K - $1.2 M
Salary
  • salary
    Unknown
Departed Administration
  • Yes

Financial Disclosure Details - OGE Form 278e (06/04/2022)

Positions Held Outside United States Government

#
Organization
City
Position
To
Nothing reported in this section

Employment Assets & Income and Retirement Accounts

#
Description
Value
Income Type
Income Amount
1
Massachusetts Audubon Society
1.1
CREF Stock R1
$1,001 - $15,000
None (or less than $201)
1.2
CREF Growth R1
$1,001 - $15,000
None (or less than $201)
2
Tufts University
2.1
TIAA Traditional
$1,001 - $15,000
None (or less than $201)
2.2
CREF Equity Index R2
$1,001 - $15,000
None (or less than $201)
2.3
TIAA Real Estate
$1,001 - $15,000
None (or less than $201)
2.4
CREF Inf-Linked Bond R2
$1,001 - $15,000
None (or less than $201)
2.5
CREF Social Choice R2
$15,001 - $50,000
None (or less than $201)
2.6
CREF Stock R2
None (or less than $1,001)
None (or less than $201)

Employment Agreements and Arrangements

#
Employer Or Party
City
Status And Terms
Date
1
Medford, Massachusetts
I will continue to participate in this defined contribution plan, but the plan sponsor no longer makes contributions.
10/2002
2
Massachusetts Audubon Society
Milton, Massachusetts
I will continue to participate in this defined contribution plan, but the plan sponsor no longer makes contributions.
6/1999

Sources of Compensation Exceeding $5,000 in a Year

#
Source
City
Duties
Nothing reported in this section

Spouse's Employment Assets & Income and Retirement Accounts

#
Description
Value
Type
Amount
1
Eastern Research Group (Environmental and Affiliated Consulting Services)
salary, bonus
2
Eastern Research Group, Inc.
2.1
American Balanced Fund Class A Shares (ABALX)
$1,001 - $15,000
None (or less than $201)
2.2
MFS Global Total Return Fund Class R3 Shares (MFWHX)
$1,001 - $15,000
None (or less than $201)
2.3
EuroPacific Growth Fund Class R5 Shares (RERFX)
$1,001 - $15,000
None (or less than $201)
2.4
T Rowe PriceEmerging Markets Stock Fund Class I Shares (PRZIX)
$1,001 - $15,000
None (or less than $201)
2.5
Vanguard Developed Markets Index Fund Admiral Class Shares (VTMGX)
$1,001 - $15,000
None (or less than $201)
2.6
DoubleLine Total Return Bond Fund Class I Shares (DBLTX)
$1,001 - $15,000
None (or less than $201)
2.7
MetLife Gac Series 25053 Class 0 (QDWFQ)
$1,001 - $15,000
None (or less than $201)
2.8
Pioneer Strategic Income Fund Class Y Shares (STRYX)
$1,001 - $15,000
None (or less than $201)

Other Assets and Income

#
Description
Value
Type
Amount
1
Capital Income Builder Class 529-A Shares (CIRAX)
$1,001 - $15,000
None (or less than $201)
2
Investment Company of America Class 529-A Shares (CICAX)
$1,001 - $15,000
None (or less than $201)
3
Capital One Savings
$50,001 - $100,000
Interest
None (or less than $201)
4
Capital One Interest Checking
$15,001 - $50,000
Interest
None (or less than $201)
5
Capital One Savings Now Account
$50,001 - $100,000
Interest
None (or less than $201)
6
Fidelity IRA
6.1
Fidelity International Growth Fund (FIGFX)
$1,001 - $15,000
None (or less than $201)
6.2
Fidelity Diversified International Fund (FDIVX)
$1,001 - $15,000
None (or less than $201)
6.3
Fidelity Extended Market Index Fund (FSMAX)
$15,001 - $50,000
None (or less than $201)
6.4
Fidelity Large Cap Stock Fund (FLCSX)
$1,001 - $15,000
None (or less than $201)

Transactions

#
Description
Type
Date
Amount
Nothing reported in this section

Liabilities

#
Creditor
Amount
Incurred
Term
Nothing reported in this section

Gifts and Travel Reimbursements

#
Source Name
City
Description
Value
Nothing reported in this section

Endnotes

Section
#
Description
Nothing reported in this section

Do you have information about Melissa Bailey that is missing from this database?

Drop us a line at [email protected].

We want your help. If you have any additional information about an appointee that is or isn’t in our database, or any corrections, let us know via email at [email protected] .

© 2024 Biden's Basement. All rights reserved